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Abstract 
 
Defining the mechanisms underlying the programming of early life growth is fundamental 
for improving adult health and wellbeing. While the association between maternal diet, 
offspring growth and adult disease risk is well-established, the effect of father’s diet on 
offspring development are largely unknown. Therefore, we fed male mice an imbalanced 
low protein diet (LPD) to determine the impact on post-fertilisation development and fetal 
growth. We observed that in preimplantation embryos derived from LPD fed males, 
expression of multiple genes within the central metabolic AMPK pathway was reduced. In 
late gestation, paternal LPD programmed increased fetal weight, however, placental weight 
was reduced, resulting in an elevated fetal:placental weight ratio. Analysis of gene 
expression patterns revealed increased levels of transporters for calcium, amino acids and 
glucose within LPD placentas. Furthermore, placental expression of the epigenetic 
regulators Dnmt1 and Dnmt3L were increased also, coinciding with altered patterns of 
maternal and paternal imprinted genes. More strikingly, we observed fetal skeletal 
development was perturbed in response to paternal LPD. Here, while offspring of LPD fed 
males possessed larger skeletons, their bones comprised lower volumes of high mineral 
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density in combination with reduced maturity of bone apatite. These data offer new insight 
in the underlying programming mechanisms linking poor paternal diet at the time of 
conception with the development and growth of his offspring.  
 
Keywords: Blastocyst metabolism; Bone health; Developmental programming; Fetal 
growth; Paternal diet; Placental function.  
 
Abbreviations 
 
AMPK 5' AMP-activated protein kinase 
DOHaD  Developmental Origins of Health and Disease  
E  Embryonic day 
FWHM Full width at half maximum 
LPD   Low protein diet 
mTORC1 mechanistic Target of Rapamycin complex 1 
NPD   Normal protein diet 
SXRD  Synchrotron x-ray diffraction 
µ-CT  micro-computed tomography  
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1. Introduction 
 
It is estimated that up to 60% of global mortality is attributed to non-communicable diseases 
such as type 2 diabetes, obesity and heart disease [1]. Typically, the risk for developing such 
disorders is associated with adult lifestyle factors including poor diet, lack of exercise and 
smoking. However, strong associations between maternal nutrition, fetal growth, weight at 
birth and an increased risk for adult-onset ill-health have been identified
 
[2, 3]. The 
Developmental Origins of Health and Disease (DOHaD) hypothesis identifies perturbed 
early life growth and nutrition as critical factors in determining adult risk for cardiovascular 
and metabolic disease. In addition, links between growth during prenatal and postnatal 
development and degenerative disorders such as osteoporosis have also been identified [2]. 
Central to elucidating the biological mechanisms underlying the programming of long-term 
ill-health has been the use of animal models. For example, modification of maternal diet or 
metabolic status in rodents exclusively during the preimplantation period of development 
has been shown to impact negatively on blastocyst metabolism and redox status [4-7], 
resulting in persistent changes in offspring growth, adult metabolic homeostasis and 
cardiovascular function [8-10]. Studies have identified that during sub-optimal 
environmental conditions, the preimplantation embryo initiates cellular and physiological 
mechanisms intended to support maximal post-implantation development and survival [4, 
10, 11]. However, the long-term consequences of these embryonic adaptive responses can 
increase cardio-metabolic and bone health disease risk in later life. Such studies reveal the 
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dynamic interaction between the embryo and the immediate environment, as well as the 
long-term impacts for offspring health. 
 
Post-implantation, the development and function of the placenta is central in the regulation 
of fetal growth. Changes in placental function may result in differential transfer of essential 
nutrients between maternal and fetal systems, programming altered fetal growth. We have 
shown that in response to maternal low protein diet (LPD, 9% protein) fed exclusively 
during the preimplantation period, early post-implantation trophoblast outgrowths display 
increased spreading and cell division phenotypes [4, 12]. Studies feeding pregnant mice [13] 
and rats [14] a LPD identify changes in placental mechanistic Target of Rapamycin 
complex 1 (mTORC1) and amino acid transporter protein expression, as well as perturbed 
gene expression for apoptosis, growth inhibition and DNA methylation processes. In 
addition, changes in placental structure, nutrient uptake and transport have also been 
reported in response to maternal diet [15-18]. These studies indicate that appropriate 
placental development and function plays a pivotal role in directing fetal growth, an 
essential indicator of postnatal offspring phenotype and disease risk. 
 
While the consequences of manipulating the maternal environment have received extensive 
investigation, the impact of paternal nutrition on the development and growth of his 
offspring remains poorly defined. However, there is now a growing body of clinical, 
epidemiological and animal model data highlighting new associations between paternal 
physiological status and offspring health [19]. Studies in humans and mice have 
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demonstrated that elevated paternal BMI impacts negatively on sperm quantity, quality, 
DNA integrity and male reproductive fitness [20-23]. Post-fertilisation, poor paternal diet 
disrupts blastocyst metabolism [24], skeletal formation [25], neonatal hepatic lipid and 
cholesterol biosynthesis, IGF-1 and corticosterone levels [26, 27], pancreatic β-cell function 
[28] and adiposity [29]. Using the well-characterised rodent LPD model, we demonstrated 
previously that offspring from LPD fed male mice were heavier at birth, displayed elevated 
adult adiposity, glucose intolerance, cardiovascular dysfunction and elevated serum TNF-α 
when compared to offspring from normal protein diet (NPD; 18% protein) fed males [30].   
 
As enhanced perinatal growth is a significant risk factor for adult health status, the aim of 
our current study was to define the mechanisms linking paternal diet with offspring 
development and growth. Here, we report that paternal LPD decreases blastocyst expression 
of multiple metabolic AMPK pathway genes, enhances fetal growth and elevates placental 
expression of central nutrient transporters and fetal growth regulating imprinted genes. In 
addition, we observe changes in fetal skeletal development and bone mineral deposition 
patterns.  
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2. Materials and methods 
 
2.1 Animal Treatments 
 
All experimental procedures were conducted using protocols approved by, and in 
accordance with, the UK Home Office Animal (Scientific Procedures) Act 1986 and local 
ethics committee at Aston University. Male (8 week old) and female (8 week old) C57BL/6 
mice (Charles River, Oxford, UK) were maintained at Aston University Biomedical Facility 
on a 07:00–19:00 light-dark cycle, temperature of 20–22°C with ad libitum access to chow 
(Special Dietary Services Ltd, UK) and water. Male mice were housed singly and allocated 
either control normal protein diet (NPD; 18 % casein; 180 g / kg diet; n = 8) or isocaloric 
low protein diet (LPD; 9% casein; 90 g / kg diet; n = 8) (Special Dietary Services Ltd, UK; 
Supplementary Table 1; protein content confirmed by manufacturer) for between 7 and 9 
weeks in total to ensure all stages of spermatogenesis and spermiogenesis were exposed to 
the diets [31]. We have reported previously on the physiological impact of LPD on paternal 
physiology [30], demonstrating no impairment in paternal fertility (sperm number, 
pregnancy rate, litter size), serum glucose, insulin or testosterone levels or in testicular 
weight when compared with NPD fed males. Virgin 8-9 week old C57BL/6 females were 
caged singly overnight with either NPD or LPD studs. Plug positive females were housed 
singly and maintained on chow ad libitum for either collection of blastocysts at E3.5, or late 
gestation fetal tissues at E17.  
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Blastocysts were flushed from the oviducts and uterus at E3.5 using EmbryoMax KSOM 
medium (Millipore; Catalogue number MR-020P-5F), washed and pooled into groups of 25, 
frozen in volumes <10µl and stored at -80
o
C ahead of PCR array analysis. At E17, dams 
were culled via cervical dislocation for the collection of fetal and extra-embryonic tissues as 
described previously [12]. Briefly, individual concepti were dissected from the uterine 
tissue and weighed prior to separation and weighing individually of the fetus, placenta and 
yolk sac. Fetal heart and liver tissues were isolated, weighed, snap frozen in liquid nitrogen 
and stored. Isolated placentae were either snap frozen or fixed in 10% formalin (Sigma, UK) 
for 24 hours at 4
o
C prior to storage in 70% ethanol at 4
o
C. In addition, whole fetuses were 
fixed in 10% formalin (Sigma, UK) for 24 hours at 4
o
C prior to storage in 70% ethanol at 
4
o
C ahead of skeletal analyses.   
 
2.2 Blastocyst AMPK RT
2
 PCR array 
 
Total RNA was isolated from eight individual pools of 25 blastocysts (four NPD and four 
LPD; each pool obtained from 4-5 females) using the RNeasy Plus Micro kit (Qiagen, UK) 
according to the manufacturer’s instructions. RNA concentration was assessed using the 
Qubit fluorometer (Thermo Scientific, UK) and equivalent quantities of RNA were 
converted to cDNA using the RT
2
 First Strand cDNA synthesis kit (Qiagen, UK) according 
to the manufacturer’s instructions. Expression of 84 AMPK signalling pathway genes (S1 
Table online) were analysed using the AMPK signalling PCR array (Qiagen, UK). 
Amplification was performed on a Stratagene Mx 3000P System (Agilent Technologies, 
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CA. USA) with resultant gene expression analysed using web-based PCR Array Data 
Analysis software (www.SAbiosciences.com). 
 
2.3 Tissue metabolite measurement, RNA extraction and transcript expression. 
 
Flushed day 3.5 maternal uteri were homogenised (50 mM HEPES, 150 mM NaCl, 1 mM 
EDTA, 1 mM EGTA, 1% SDS) prior to protein level determination (DC assay, Bio-Rad 
Laboratories) and glucose level analysis by glucose oxidase assay (Sigma, UK) in 
accordance with the manufacturer’s instructions, and measured on a Benchmark microplate 
reader (Bio-Rad Laboratories, UK).  
 
RNA was isolated from placental and fetal liver using the RNeasy Mini Kit (Qiagen, UK) 
with additional on-column DNase I digestion (Qiagen, UK), prior to cDNA synthesis 
(nanoScript 2 reverse transcription kit; Primerdesign, UK), all according to manufacturer’s 
instructions. For Real-Time PCR (qRT-PCR), 5 ng cDNA was added to a mastermix 
comprising 10 µl 2X mastermix (Precision SYBRgreen Mastermix; Primerdesign, UK), 5 
µM forward and reverse primers and 8.3 µl water per reaction. Amplification and detection 
was performed using a Stratagene Mx 3000P System (Agilent Technologies, USA). The 
expression levels of the samples were calculated using the ΔΔCT method with placental data 
normalised to the expression of Sdha and Tbp and liver tissue data normalised to Pgk1 and 
Tbp [32, 33]. Reaction specificity was confirmed by dissociation curve analysis. Primer 
sequences are provided in Supplementary Table 3. 
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2.4 Determination of fetal sex and placental histology  
 
DNA was extracted from fetal tail tissue using the DNeasy Blood and Tissue kit (Qiagen, 
UK) according to the manufacturer’s instruction. For PCR determination of fetal sex, 2 µl 
(100 ng) of template DNA was added to a mastermix comprising 12.5 µl mastermix (2X 
JumpStart Taq; Sigma), 2.5 ul primer mix (25 µM forward and reverse primers) and 8 µl 
water per reaction. Amplification was performed using an Eppendorf (Mastercycler® Pro) 
thermocycler using primers specific for regions on the Y (Sry) and X (Dxnds3) 
chromosomes (primer sequences are provided in Supplementary Table 3).  
 
Formalin fixed placentas from five male and five female fetuses per diet group (only one 
male and female taken from any individual dam, n = 5 dams per diet group) were embedded 
in paraffin wax. From each placenta, 4 midsagittal 5 µm sections were taken from the 
midline of the placenta. Sections were mounted onto slides ahead of haematoxylin and eosin 
staining. Sections were imaged using a      CETI Magnum-T microscope and a Jenoptik 
ProgRes CF camera prior to determination of total junctional and labyrinthine zone areas 
using Volocity software. Areas were expressed as proportion (percentage) of total 
midsagittal area comprised by junctional and labyrinthine zones. 
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2.5 Fetal bone analyses  
 
2.5.1 Whole fetal µ-CT analysis 
 
Whole formalin fixed fetuses were scanned using a Skyscan 1172 in vivo µ-CT scanner 
(Bruker, Belgium). All scans were taken at 50 kVa and 170 µA with a 0.5 mm aluminium 
filter, 700 ms exposure time, 180
o
 tomographic rotation. Individual two-dimensional cross-
sectional images were reconstructed using Bruker NRecon software (version 1.6.10) and 
were analysed using Bruker CTAn software (version 1.15). Voxel resolution was 13.5 µm. 
After 3D reconstruction of each fetal mouse, bony tissues were determined by a global 
threshold that was set using a combination of visual inspection of the 2D images and the 
analysis of associated histograms. Bony tissue was identified in all individual fetuses. A 
threshold for bony tissue was set at 700 Hounsfield Units following visual confirmation in 
all samples. Using this threshold, a clear distinction between bone, surrounding soft tissue 
and ringing artefacts (inconclusive signals near sharp transitions) could be made.  
 
2.5.2 Synchrotron x-ray diffraction (SXRD) 
 
The right femur and humerus from formalin fixed NPD and LPD fetuses were dissected 
clean of surrounding muscle and connective tissue and stored in 70% ethanol at 4
o
C. SXRD 
measurements of NPD and LPD offspring fetal femur and humerus bones were conducted at 
beamline B16 Diamond Light Source (Oxford Harwell Campus, Didcot, UK). Bones were 
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mounted normal to the impinging X-rays in transmission geometry to allow measurements 
in two orthogonal directions perpendicular to the X-ray beam. An incident X-ray energy of 
17 keV was used, equivalent to a wavelength (λ) of 0.7293 Å, with a beam size of 35 µm.  
For each sample, three separate line transects separated by 1 mm above and below the 
midline of the bone were scanned in 25 µm increments and an exposure time of 60 seconds. 
Diffraction data was collected using a 2D area detector (Image Star 9000, Photonic Science 
Ltd. UK) with a 3056 x 3056 pixel resolution, placed 110 mm behind the sample to give a 
2θ range of 5-33°. Measurements were taken also for the direct beam, empty sample 
containers, beryllium windows and water, with all measurements and instrument parameters 
determined against silicon and lanthanum hexaboride (LaB6) standards. 
 
2.5.3 SXRD data analysis 
 
Diffraction data were normalised and background corrected using the Fit2D software 
package (version 12.077, ESRF). Diffraction patterns were azimuthally integrated to 
produce 1D spectra of intensity (I) versus the scattering angle (2θ). The Bragg peak 
corresponding to the (002) (~13°) reflection was fitted with a Gaussian peak shape to obtain 
the peak position and the full width at half maximum (FWHM) to quantify possible changes 
to the crystal structure from the lattice parameters. Additionally, Rietveld refinement was 
used to determine changes in the lattice parameters and texture coefficients (General 
Structure Analysis System package). A hexagonal unit cell with a P63/m symmetry space 
group was assumed for the hydroxyapatite structural model with initial lattice parameters 
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[34]. The positions of the (002) and (300) planes were used calculate the hydroxyapatite 
unit cell c and a axis lattice parameters. Peak positions were used to determine the inter-
planar spacing (d), where            (here θ is equivalent to half the angle between the 
incident X-rays and the detector), from which lattice parameters were calculated. A 
hexagonal unit cell was assumed for hydroxyapatite, where the relationship between the d 
spacing, Miller indices for a given Bragg peak and lattice parameters are given as;  
 
 
  
 
 
 
 
         
  
   
  
  
 
 
2.5.4 Fetal femur Inductive Coupled Plasma (ICP) elemental analysis 
 
Isolated formalin-fixed fetal right femurs were digested (1 ml concentrated nitric acid, 20 
mg of ammonium fluoride) using in a CEM SP-D discover microwave digester (190
o
C for 
20 minutes, 300W power). Samples were diluted with 4 ml of deionised water prior to ICP 
analysis for calcium and phosphorus content using an iCAP 7000 ICP-OES system and 
measured against AAS standards for calcium and phosphorus (Sigma, UK). The R-squared 
of the calcium and phosphorus calibration curves were 0.9991 and 0.9993 respectively. 
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2.6 Statistical analyses  
 
Data were assessed for normality (Shapiro–Wilk test) and correlations between phenotypic 
measurements (Pearson correlation) using SPSS (Version 21). Analysis of fetal weights, 
bone development and placental morphology were analysed using a multilevel random 
effects regression model (SPSS version 21), adjusting for paternal duration on respective 
diet (number of days), paternal origin of litter, gestational litter size and body weight effects 
where appropriate [10]. Where a significant effect of sex was observed, data for each sex 
were analysed separately and reported as such. Significance was taken at P<0.05. 
 
3. Results 
 
3.1 Paternal LPD reduces blastocyst AMPK signalling pathways gene expression  
 
Virgin 8-week old female C57BL6 mice were mated with either NPD or LPD fed male 
C57BL6 mice for the collection of mid-late stage (E3.5) blastocysts. We observed no 
significant difference in the mean number of blastocysts collected from NPD or LPD mated 
females (NPD = 8.6 ± 0.2, LPD = 8.4 ± 0.4; P = 0.84). Four pools of 25 mid-late blastocysts 
were collected for each paternal dietary group ahead of AMPK pathway PCR array analysis. 
In total, 71 genes were decreased in their relative expression and 18 genes were increased in 
LPD blastocysts (Fig. 1A) (see Supplementary Table 2 for array gene list, fold expression 
differences and individual P values). There was no significant difference in the expression 
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of any of the reference genes (Actb, B2m, Gapdh, Gusb, Hsp90ab1) between groups (P < 
0.1). In LPD blastocysts, 16 genes were identified as being significantly decreased in their 
expression, relative to NPD blastocysts (P < 0.05), while no genes displayed a significant 
increase in expression. Gene function analysis of the differentially expressed genes 
characterised them into the following biological processes: metabolism (Cpt1b, Slc2a4) 
(Fig. 1B), receptors (Adra1b, Adra2b, Adipor1) (Fig. 1C), transcription regulation (Crtc2, 
Foxo3, Trp53) (Fig. 1D), signalling cascades (Akt2, Pdpk1, Prkab1, Ppp2r4) (Fig. 1E) and 
protein synthesis and autophagy (Eef2k, Rb1cc1, Stradb, Ulk1) (Fig. 1F). Analysis of 
flushed maternal uterine tissue revealed significantly lower glucose levels in females mated 
with LPD fed males; NPD = 2.27 ± 0.21, LPD = 1.15 ± 0.28 µg/ml/mg uterus (P = 0.007). 
 
3.2 Fetal growth and placental development are altered by paternal LPD 
 
As fetal growth is reflective of weight at birth, postnatal growth and adult disease risk, we 
investigated whether paternal LPD influenced late gestation (E17) fetal development. At the 
time of cull, paternal LPD had no effect on mean litter size (NPD = 8, LPD = 8; P = 0.52) or 
maternal weight gain (NPD = 9.3 ± 0.4g, LPD 8.9 ± 0.5g; P = 0.59). In addition, there was 
no effect of the number of days individual males were fed LPD on fetal weight (P = 0.59), 
placental weight (P = 0.71) or on fetal:placental weight ratio (P = 0.66).  In LPD offspring, 
we observed a similar weight of the conceptus (combined fetal, placental and yolk sac 
weight; P = 0.06) but elevated weight of the isolated fetus (P = 0.012), while placental 
weight was decreased significantly (P = 0.011) (Fig. 2A). There was no difference in mean 
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yolk sac weight between groups (Fig. 2A). While fetal heart weight was not different 
between NPD and LPD offspring (data not shown), fetal liver weight was increased 
significantly in LPD offspring (NPD = 42.7 ± 1.0 mg, LPD = 47.0 ± 0.9 mg; P = 0.005). 
Analysis of organ:body weight ratios revealed a significantly decreased fetal:placenta 
weight ratio (P< 0.0001), but no difference in fetal:liver or fetal:heart ratios (Fig. 2B). To 
determine whether changes in AMPK metabolic signalling established within the 
preimplantation embryo persisted into fetal tissues, we determined the expression of 6 genes 
in the fetal liver differentially expressed from our blastocyst array. We chose to study genes 
involved in a broad range of cellular processes to ascertain the potential scope of differences 
being maintained into late gestation fetal tissues. Here, the expression of Adipor1, Akt2, 
Prkaca, Ppargc1a and Trp53 were all reduced significantly in LPD livers (Fig. 2C; P < 
0.05), mirroring LPD embryonic expression profiles.  
 
3.3 Paternal LPD alters placental morphology and gene expression 
 
Placental development and function are central regulators of fetal growth. Therefore, we 
assessed the placental morphology and gene expression patterns in response to paternal diet. 
NPD and LPD placentas displayed equivalent mean mid-line placental cross sectional area 
(Fig. 3B), with no differences in mean labyrinth zone, junctional zone or trophoblast areas 
(Fig. 3B). However, when assessed as relative proportions of the whole placental area, a 
significant reduction in labyrinth and increase in junctional zones were observed in LPD 
placentas (P = 0.028 and 0.002 respectively; Fig. 3C). As an increased fetal:placental ratio 
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indicates net flux of nutrients to the fetus per gram placenta is upregulated, we assessed 
placental expression of key nutrient transporters. Here, expression of the calcium (Atp2b1), 
neutral amino acid (Slc38a2) and glucose (Slc2a1, Slc2a4) transporters were increased 
significantly in LPD placentas (Fig. 3D, P < 0.05). No difference in the expression of the 
parathyroid hormone receptor (Pthr1) or vitamin D3 receptor (Vdr) were observed between 
groups. In addition, increased expression of DNA methyltransferase 1 and 3L (Dnmt1, 
Dnmt3L) (Fig. 3E), and differential expression of the maternally imprinted Cdkn1c, H19, 
and Grb10 and paternally imprinted Mest and Snrpn genes were observed in LPD placentas 
(Fig. 3F; all P < 0.05).  
 
3.4 Paternal LPD modifies fetal skeletal development and bone crystallographic 
morphology 
 
To determine whether the enhanced fetal growth observed in LPD offspring was driven by 
changes in skeletal formation, we assessed whole fetal skeletal morphology using micro 
computed tomography (µ-CT) (Fig. 4A). Despite there being no difference in whole skeletal 
bone mineral density (Fig. 4B), LPD offspring displayed a significantly increased mean 
skeletal volume (Fig. 4C, P = 0.037). As a consequence of the increased LPD skeletal 
volume, mean total litter mineral content was elevated by 47% (Fig. 4D, P = 0.037). 
Analysis of whole skeletal mineral distribution, revealed an increase in total area of 
mineralised bone (Fig. 4E), reflective of the increase in bone volume in LPD offspring. 
However, LPD skeletons displayed significantly increased proportions of low mineral 
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density bone (700-1290 Hounsfield units, Fig. 4F, G, P < 0.0001) but decreased proportions 
of high mineral density bone (1300-1900 Hounsfield units, Fig. 4F, H; P  < 0.01). 
 
To quantify further the impact of paternal diet on offspring bones, we analysed fetal femur 
and humerus hydroxyapatite crystalline structure by X-ray diffraction (Fig. 5B). As no 
difference in hydroxyapatite crystalline structure was observed between humerus and femur 
bones (data not shown), data from each bone were combined and are presented as an 
average. We observed differences in the scattering angle spectra with significant broadening 
in the LPD bones (Fig. 5C). Analysis of a=b lattice (16
o 
scattering angle) and c lattice (13
o
 
scattering angle) parameters revealed increases in the mean lattice parameters for LPD 
offspring (Fig. 5D, F; P <0.001) with concordant increases in mean lattice full width half 
maximum values (Fig. 5E, G; P < 0.001). Analysis of the a/c lattice ratio revealed similar 
mean values of 0.707 and 0.709 for NPD and LPD bones respectively. To determine 
whether the changes in hydroxyapatite lattice parameters were as a result of changes in bone 
mineral composition, we performed Inductive Coupled Plasma (ICP) elemental analysis on 
individual fetal femurs. We observed no difference in bone calcium or phosphorus content, 
or in their ratio (Table 1).  
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4. Discussion 
 
Defining the mechanisms underlying the aetiology of adult-onset disorders such as obesity, 
heart disease and osteoporosis are of considerable relevance to current human health 
concerns. Strong associations between maternal diet, altered embryonic and fetal 
development and increased adult-onset disease risk in her offspring are well established. 
However, our understanding of the impact paternal diet has on post-fertilisation 
development and adult offspring health remains ill-defined. Previously, we demonstrated 
that a nutritionally imbalanced paternal LPD in mice elevated offspring growth, increased 
adult fat mass, impaired glucose tolerance and cardiovascular function [30]. As increased 
perinatal growth is a significant risk factor for adult health, the aim of this current study was 
to define the impact of paternal diet on post-fertilisation development and fetal growth 
regulation. In response to paternal LPD, we observed persistent programming of multiple 
AMPK genes, established within the preimplantation embryos and still evident in the late 
gestation fetal liver. In addition, we observed enhanced fetal growth, coinciding with 
elevated expression of placental nutrient transporters and imprinted genes. Finally, we 
observed that while offspring of LPD males had increased skeleton volume, their bones 
comprised higher volumes of low mineral density.  
 
Paternal LPD reduced blastocyst expression of 16 genes within the central cellular 
metabolic AMPK pathway. We observed decreased expression of genes for receptors, 
signalling cascades, protein synthesis and autophagy, transcription regulation and 
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metabolism biological processes. Of note, we observed reductions in the expression of the 
adiponectin receptor 1 (Adipor1), the facilitated glucose transporter 4 (Slc2a4) and the 
energy sensing non-catalytic subunit of AMPK (Prkab1), as well as insulin receptor (Insr; at 
a trend level). Together, these observations indicate a reduced metabolic status within LPD 
embryos. In response to a drop in intracellular ATP levels, AMPK stimulates the uptake of 
glucose and oxidation of fatty acids and inhibits the synthesis of cholesterol and 
triglycerides [35]. In mammalian preimplantation embryos, glucose is the predominant 
energy substrate with mouse embryos capable of additionally metabolising fatty acids [36]. 
In both mouse and human embryos, while glucose uptake correlates positively with 
embryonic development, blastocoel formation and post implantation survival [37, 38], lower 
glycolytic rates (the conversion of glucose to lactate) are observed in ‘faster’ developing 
mouse embryos [38]. Conversely, lower rates of amino acid and glucose metabolism in 
human embryos have been attributed to increased developmental potential [39]. Therefore, 
the reduced expression of Slc2a4, Adipor1 and Prkab1 observed in LPD blastocysts may be 
a direct adaptive response initiated to modify metabolism in order to enhance post-
implantation survival.  
 
In line with reduced signalling via metabolic receptors, we observed that paternal LPD 
reduced the expression of signal transduction regulators Akt2 and Pdpk1 in LPD blastocysts. 
Akt and Pdpk1 have key roles in the regulation of cellular migration, metabolism 
mitogenesis, differentiation and survival through their down-stream interaction with 
mTORC1 [40]. In response to growth factor receptor signalling, mTORC1 stimulates the 
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biosynthesis of proteins, lipids and nucleic acids via the actions of the down-stream 
substrates ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-
binding protein (4E-BP) [41]. Changes in mouse blastocyst signalling via the mTORC1 
pathway have been demonstrated in response to uterine amino acid and insulin 
concentrations [4]. Therefore, it cannot be discounted that changes in blastocyst metabolism 
and downstream signalling mechanisms may have occurred in response to paternal 
modulation of the maternal pre-implantation uterine environment. Indeed, we observed 
reductions in maternal uterine glucose levels at the time of implantation in females mated 
with LPD fed males. Changes in uterine metabolite levels have been observed in response to 
maternal LPD [4] associated with enhanced fetal growth and adult cardiovascular and 
metabolic ill-health in mice [9, 10]. Studies have also shown that seminal plasma can impact 
on rodent, porcine and human female reproductive tract physiology [42, 43]. The presence 
of seminal plasma at the time of mating is essential for the appropriate oviductal expression 
of several embryotrophic factors including Lif, IL6, Csf and Egf and the pro-apoptotic factor 
Trail in mice [44]. In line with these studies, we observed decreased expression of the 
transformation related protein 53 (Trp53) in LPD blastocysts. Trp53 acts as a tumour 
suppressor in many cell types either by reducing cell cycle progression or by induction of 
pro-apoptotic factors. While increased expression of Trp53 is associated with poor 
embryonic developmental capacity in both mice and humans [45, 46],  
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Trp53
-/- 
mouse blastocysts display increased viability post-transfer and are more likely to 
result in a viable fetus [47]. These data indicate that paternal diet may modify blastocyst 
metabolism and survival directly as well as via modulation of the maternal uterine 
environment. However, further mechanistic studies are required to determine the association 
of paternal diet with modified preimplantation embryo metabolism and gene expression and 
their impact on subsequent developmental potential.   
 
Our second key finding was that in late gestation, fetal growth was increased in response to 
paternal LPD while placental size was decreased. The mechanisms underlying the reduced 
size of the mature placenta in females mated with LPD fed males remain unclear. Maternal 
LPD fed exclusively during the preimplantation period modifies blastocyst allocation to the 
trophectoderm lineage with consequent changes in trophoblast out-growth phenotype [4, 
12]. Therefore, reduced placental weight may be reflective of differential cell lineage 
allocation in the early embryo, driven either by uterine changes in specific nutrients and/or 
perturbed blastocyst metabolic signalling. The observation that despite a significant 
reduction in LPD placental mass, LPD offspring fetal weight was enhanced, suggests 
placental transport flux of nutrients to the fetus was upregulated. Therefore, we determined 
the expression levels of placental transporters central in the regulation of fetal growth. 
Paternal LPD resulted in an increased expression of specific transporters of glucose (Slc2a1, 
Slc2a4), neutral amino acids (Slc38a2) and calcium (Atp2b1). Elevated placental expression 
and activity of glucose and System A and L amino acid transporters are associated with 
increased fetal growth in women with type-1 diabetes [48, 49]. Similarly in obese women, 
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increased amino acid transporter activities correlate positively with fetal growth [50], while 
placental size and calcium transporter gene expression have been shown to predict offspring 
bone mass at birth [51, 52]. Therefore, up-regulation of placental nutrient transporter 
expression appears a central mechanism in the regulation of fetal growth, whatever the 
underlying environmental cause. In contrast, the impact of paternal physiological status on 
placental development has remained largely unexplored. In a mouse model of paternal 
dietary-induced obesity, sex-specific changes in placental expression of Ppara and Casp12 
have been observed [53], while a paternal low folate diet modified placental expression of 
genes associated with gene transduction and cell signalling [25]. Thus, programming of 
enhanced placental nutrient transport may underlie the enhanced fetal growth trajectory 
induced by paternal LPD. However, the conclusion drawn from our current study are 
limited by our observations being taken only at the gene expression level.  It is essential that 
our future studies validate these changes at the protein level in order to determine fully the 
impact of paternal diet on fetal growth regulation and the underlying mechanisms involved. 
In addition, it would also be beneficial to measure placental function and nutrient transport 
flux in response to paternal diet.  
 
The paternal epigenome also plays a substantial role in directing fetal growth through 
regulation of placental development and function [54]. In mammals, fetal growth and 
placental transport of nutrients are regulated tightly by the expression of parent-of-origin 
specific imprinted genes [55]. Imprinted genes have evolved to regulate maternal resource 
allocation to the developing fetus, with paternal imprints allocating resources to the fetus 
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and maternal imprints retaining them. In LPD placentas we observed increased levels of the 
maternally-expressed Cdkn1c, H19 and Grb10, while the paternally-expressed Mest and 
Snrpn were increased and decreased respectively. In addition, we observed increased Dnmt1 
and Dnmt3L expression in LPD placentas. Cdkn1c encodes a cyclin-dependent kinase 
inhibitor that negatively regulates cell proliferation [56]. Reduced placental expression of 
Cdkn1c is associated with increased placental size and disproportionate labyrinth/junctional 
zone proportions [56, 57]. Similarly, disruption of the maternal Grb10 allele also results in 
overgrowth of both the placenta and the fetus via enhanced placental efficiency [58, 59]. 
The paternally expressed Mest is restricted to fetal endothelial cells of the labyrinth [60] 
with loss of function resulting in reduced placental size and fetal growth [61]. It was of 
interest to note that while we observed increased expression of H19, no difference in Igf2 
was detected. As Igf2 and H19 expression are regulated reciprocally from the same 
differentially methylated element, an increase in H19 should result in a decrease in 
expression of Igf2.  However, as we did not measurement parental allele-specific 
expression, or Igf2 at the protein level, this may account for the lack of difference observed. 
Similarly, we did not determine the impact of our observed changes in Dnmt1/3L expression 
on placental gene methylation status or expression profile. Our observations of decreased 
placental size in conjunction with increased expression of maternal Cdkn1c, H19 and 
Grb10, as well as decreased paternal Snrpn, indicate a maternal adaptive mechanisms to 
restrict fetal growth in response to paternal LPD. However, the increased placental 
expression of nutrient transporters may ultimately result in the elevated fetal growth 
observed. It is also possible that LPD induced changes in paternal gene expression may also 
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influence placental function and offspring development independent of direct transmission 
of genetic effects [62, 63]. Therefore further studies are needed, not only to address our 
study limitations and validate the gene expression changes observed for regulators of 
epigenetic mechanisms, but also to understand the heritability and paternal genomic 
mechanisms of fetal programming.  
 
Our third main finding was that paternal LPD modified the development of the fetal 
skeleton. While the skeletal volume of LPD fetuses was increased, we observed that their 
bones comprised lower levels of high density hydroxyapatite mineral deposition. Studies in 
humans and rodent models have shown that appropriate development of the fetal skeleton 
appears to be a fundamental prerequisite for optimal adult bone health. In humans, fetal 
femur longitudinal growth predicts skeletal size at age 4 years [64], and variation in older-
adult bone mass is highly correlated with prenatal skeletal development and birth weight 
[65]. Human studies demonstrate also that nutritionally induced delays in bone maturation 
increase hip fracture risk, reduce bone mineral accrual and induce disproportionate bone 
growth in adulthood [66, 67]. In rodents, maternal LPD has been shown to reduce femoral 
neck thickness, trabecular density and femoral and tibia strength in adult offspring [68]. 
Conversely, a paternal low folate diet in mice results in an increase in fetal skeletal defects 
[25], while sperm DNA damage has been associated with embryonic malformations  [69].  
These data indicate that while paternal LPD promotes overall bone size and skeletal growth, 
their composition appears sub-optimal. 
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The changes in offspring bone mineral distribution were observed alongside significant 
crystallographic changes in bone apatite. We observed that in femurs and humerus bones of 
offspring from LPD fed males, both a=b and c lattice parameters were increased 
significantly from those of NPD offspring. Such changes are usually ascribed to either 
compositional variation in the apatite crystallites [70, 71] or crystallographic differences 
relative to the crystallite particle morphology [72] manifested due to the presence of internal 
residual strains. We observed that the ratio of the unit cell parameters c/a remained similar 
between NPD and LPD diets at 0.707 and 0.709 respectively. These differences are 
therefore more likely to be related to growth-rate induced effects than phenomena 
associated with (later) bone maturation where typically the a-lattice decreases whilst the c-
lattice remains constant [73]. Similarly, the lack of distortion of the unit-cell (lack of 
changes to the c/a ratio) suggests that in this case, differences in macroscopically manifested 
residual stresses in LPD and NPD bone are unlikely to account for the observed changes to 
the unit-cell as such stresses in bone are deviatoric. Within bone the chemical composition 
of hydroxyapatite varies. Although no quantitative phase analysis was undertaken it is well 
accepted that with bone growth and maturation, there is an increase in bone crystallinity, a 
matched crystallite growth and a reduction in lattice size [63]. Changes in the lattice 
parameters of early forming bone can inform on compositional differences of the maturing 
bone apatite. Studies have demonstrated that the substitution of apatite OH
-
 and PO4 ions 
with Cl
-
 and HPO4
2-
 respectively, significantly lengthens the a=b apatite axis [64], while the 
substitution of PO4 by CO3 increases the apatite c lattice axis [65]. In addition, changes in 
lattice parameters have been identified based on the analysis of calcium and phosphorus 
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content during the early stages of ossification in animal [65, 66] and human [63] studies. 
Here, developing bone is seen as a mixture impure hydroxyapatite with calcium-phosphate 
phases comprising different calcium:phosphate ratios. As bones mature, the calcium content 
increases as a function of age. However, our elemental analysis of NPD and LPD fetal 
femurs revealed no significant difference in mean calcium or phosphorus content, or in their 
relative ratio. One main limitation to elemental analysis is that it cannot discriminate 
between calcium contained within a crystalline state and that within more amorphous states. 
Our data suggests that the more rapid skeletal growth associated with the LPD diet is 
associated with smaller crystallite sizes and increased unit-cell lengths which are in contrast 
to the expected observation of an increased crystallite size with age/growth rate and a 
reduction of unit-cell lengths bone maturation [70]. These findings indicate undescribed 
perturbation of bone growth with disruption of ‘normal’ mineralization at the ultrastructural 
level. Although the exact physico-chemical mechanisms could not be elucidated there are 
clear implications on bone function and further studies to determine whether this is a delay 
in ossification or a more permanent disruption of ossification are required.   
 
Conclusions 
 
We have demonstrated that paternal LPD perturbs blastocyst metabolic AMPK gene 
expression, potentially as an adaptive mechanism to preserve embryo viability. Analysis of 
late gestation fetal liver tissues revealed identical expression profiles for several of the same 
genes indicating persistence in paternally programmed metabolic function between the 
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embryo and late gestation differentiated tissues. Furthermore, we observed that paternal 
LPD enhanced fetal growth potentially through elevated expression of placental nutrient 
transporter and modified patterns of imprinted gene expression. Finally, we observed that 
while paternal LPD promoted increased fetal skeletal growth, bone mineral distribution was 
impaired. These studies highlight the importance of paternal nutrition at the time of 
conception for the post-fertilisation development and growth of his offspring. While these 
adaptive changes in developmental trajectory may confer short-term advantage, for example 
in post-implantation survival or post-natal reproductive fitness, they result ultimately in an 
increased predisposition for adult-onset chronic disease in later life. However, our current 
conclusions are limited in their scope and require additional studies to confirm whether our 
observed changes at the gene levels are reflected in changes at the protein levels. In 
addition, it is essential that we defining further the precise mechanisms underlying the 
programming of offspring development in relation to paternal diet.  
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Table 1. Fetal femur weight and Inductive Coupled Plasma (ICP) elemental analysis 
 
 
NPD LPD 
Right Femur weight (mg) 0.30  ± 0.02
a 
0.38  ± 0.02
b 
Right Femur calcium content (%/mg 
bone) 4.29  ± 0.53
a 
4.12  ± 0.21
a 
Right Femur phosphorus content (%/mg 
bone) 3.52  ± 0.38
a 
3.47 ± 0.14
a 
Right Femur calcium:phosphorus ratio 1.21  ± 0.03
a 
1.20  ± 0.03
a 
 
All data are expressed as mean ± SEM. Different superscript letters denote significance at 
P < 0.05. n = 8 femurs per dietary group, each from different litters. 
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Fig 1. Paternal LPD modifies preimplantation blastocyst AMPK pathway gene 
expression. 
 
Fold expression change in LPD blastocysts for all array genes analysed compared with NPD 
genes (a). Relative LPD E3.5 blastocyst expression of genes involved in (b) metabolism, (c) 
receptors, (d) transcription regulation, (e) signalling cascades and (f) protein synthesis 
within the AMPK pathway. NPD blastocyst expression is normalised to 1; n = 4 pools of 25 
blastocysts, each pool generated from 4-6 females for each dietary group. Expression data 
was analysed using the web-based PCR Array Data Analysis software 
(www.SAbiosciences.com). Bars in A represent mean with 5-95 percentile. Scatter plots 
display mean ± SEM. *, P < 0.05; **, P < 0.01. 
 
Fig 2. Paternal LPD enhances late gestation fetal growth.  
 
Mean weight of concepti, fetal and extra-embryonic tissues (a) and fetal:organ weight ratios 
(b) for offspring from NPD and LPD fed males at E17. Fetal liver expression of AMPK 
pathway genes (C); relative expression for NPD fetal livers are normalised to 1. Fetal 
weights are from a total of 54-59 individual fetuses from 8 litters per treatment group, each 
from different males. All data were analysed using a multilevel random effects regression 
analysis. Liver expression data are from 8 individual fetuses per treatment group, each from 
separate litters.  Values are mean ± SEM. *, P < 0.05; ***, P < 0.001. 
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Fig 3. Paternal LPD modifies late gestation placental development, nutrient 
transporter and imprinted gene expression. 
 
Representative mid-sagittal histological image of a late gestation placenta displaying the 
trophoblast (Tr), junctional (Jz) and labyrinth (Lz) zone regions (a). Total cross-sectional 
area of mid-sagittal sections of placental tissue and individual regions (b). Relative 
proportion of trophoblast, junctional zone and labyrinth zone as a percentage of the whole 
cross-sectional area (c). Relative LPD expression of placental transporters (d), DNA 
methyltransferases (e) and imprinted genes (f); expression for NPD placentas is normalised 
to 1. Placental morphology data are from 10 placentas per treatment group (taken from all 8 
litters per treatment group). Gene, expression analysis was conducted on 8 separate 
placentas per treatment group, one placenta per litter per treatment group. All data were 
analysed using a multilevel random effects regression analysis. Values are mean ± SEM. *, 
P < 0.05; **, P < 0.01. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
 
 
48 
 
 
 
 
Fig 4. Paternal diet increased late gestation fetal skeletal volume but impairs bone 
mineral distribution. 
 
Representative µ-CT image of a whole E17 fetal skeleton (a). Offspring whole skeletal bone 
mineral density (b). Offspring whole skeletal volume (c). Litter total mineral content (d). 
Offspring skeletal mineral density distribution and area under the distribution curve (insert) 
(e). z-score transformation of offspring skeletal mineral density distribution (f). Area of 
offspring bone displaying low (g) or high (h) mineral density. Values in b, c, d, e, g and h 
are mean ± SEM. Values in F are standardised to a mean of 0 with an SD of 1. All data are 
from 8 fetuses per treatment group, one fetus per litter per treatment group. All data were 
analysed using a multilevel random effects regression analysis. *, P < 0.05; **, P < 0.01; 
**** P, < 0.0001. 
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Fig 5. Paternal LPD modifies fetal bone hydroxyapatite crystal structure 
 
Diagram of atomic organisation and lattice plane orientation of hydroxyapatite (a). 
Representative X-ray diffraction pattern showing characteristic 002 and 300 rings (b). X-ray 
diffraction spectra (Q) averaged for NPD and LPD fetal humerus and femur hydroxyapatite 
(c). NPD and LPD fetal femur hydroxyapatite a=b lattice (d), a=b lattice full width half max 
(e), c lattice (f) and c lattice full with half max parameters (g). Values in b-d are mean ± 
SEM. All data are from 8 fetuses per treatment group, one fetus per litter per treatment 
group. All data were analysed using a multilevel random effects regression analysis. ****, P 
< 0.0001. 
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Highlights for BBADIS-16-620 
 
 Paternal low protein diet (LPD) perturbs blastocyst AMPK pathway gene expression 
 Paternal LPD enhances fetal growth but diminishes placental size 
 Elevated growth coincides with increased placental nutrient transporter expression  
 Fetal skeletal development and bone mineral deposition are impaired by paternal LPD 
